Comparison of Different Risk Scores for Prediction of In‐Hospital Mortality in STEMI Patients Treated with PPCI
CH Wang, HT Wang, KH Wu, FJ Cheng… - Emergency Medicine …, 2022 - Wiley Online Library
Background. Several risk scores have been developed to predict and analyze in‐hospital
mortality and short‐and long‐term outcomes of ST‐elevation myocardial infarction (STEMI) …
mortality and short‐and long‐term outcomes of ST‐elevation myocardial infarction (STEMI) …
Bedside prediction of 9-year mortality after ST‑segment elevation myocardial infarction treated with primary percutaneous coronary intervention
M Polańska-Skrzypczyk, M Karcz… - Kardiologia Polska …, 2019 - journals.viamedica.pl
Background: Despite similar underlying pathogenesis, clinical features, and management of
ST‑segment elevation myocardial infarction (STEMI), the long‑term prognosis of patients is …
ST‑segment elevation myocardial infarction (STEMI), the long‑term prognosis of patients is …
P3635 Comparison of short-term and long-term mortality between patients with ST-and non ST-segment elevation myocardial infarction in three French population …
V Bongard, J Ferrieres, J Dallongeville… - European Heart …, 2017 - academic.oup.com
Background: Data are sparse regarding comparative short-term and long-term mortality
across patients presenting with ST-segment elevation myocardial infarction (STEMI) and …
across patients presenting with ST-segment elevation myocardial infarction (STEMI) and …
[HTML][HTML] Biomarkers for risk stratification of patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention: Insights from the …
MA Velders, L Wallentin, RC Becker, AJ van Boven… - American heart …, 2015 - Elsevier
Background The incremental prognostic value of admission measurements of biomarkers
beyond clinical characteristics and extent of coronary artery disease (CAD) in patients …
beyond clinical characteristics and extent of coronary artery disease (CAD) in patients …
Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI
F Roubille, A Samri, L Cornillet… - European journal of …, 2010 - Elsevier
INTRODUCTION: We assessed the long-term prognostic value of an easy-to-do multiple
cardiac biomarkers score after a revascularized acute myocardial infarction (MI) in order to …
cardiac biomarkers score after a revascularized acute myocardial infarction (MI) in order to …
The long-term prognostic value of multiple biomarkers following a myocardial infarction
T Brügger-Andersen, H Aarsetøy, H Grundt… - Thrombosis research, 2008 - Elsevier
INTRODUCTION: We assessed the long-term prognostic value of multiple cardiac
biomarkers after an acute myocardial infarction (MI) in order to evaluate a multimarker …
biomarkers after an acute myocardial infarction (MI) in order to evaluate a multimarker …
Evaluation and Comparison of the STIMUL Extended and Simplified Risk Scores for Predicting Two-Year Death in Patients Following ST-Segment Elevation …
S Korol, A Wsol, A Reshetnik, A Krasyuk… - Medicina, 2021 - mdpi.com
Background and Objectives: The management of ST-segment elevation myocardial
infarction (STEMI) requires a patient's long-term risk to be estimated. The objective of this …
infarction (STEMI) requires a patient's long-term risk to be estimated. The objective of this …
Early survival after acute myocardial infarction with ST-segment elevation: What could be improved? Insights from France PCI French registry
B Duband, P Motreff, P Marcollet, A Gamet… - Medicine, 2022 - journals.lww.com
Early mortality post-ST-segment elevation myocardial infarction (STEMI) in France remains
high. The multicentre France Percutaneous Coronary Intervention Registry includes every …
high. The multicentre France Percutaneous Coronary Intervention Registry includes every …
A comparison of risk scores' long-term predictive abilities for patients diagnosed with ST elevation myocardial infarction who underwent early percutaneous coronary …
A Aldujeli, A Haq, A Hamadeh… - Scandinavian …, 2022 - Taylor & Francis
Objective. To compare the long-term (5 year) prognostic values of commonly used risk
scores on major adverse cardiovascular events (MACE) in a cohort of patients who …
scores on major adverse cardiovascular events (MACE) in a cohort of patients who …